Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial-Reference-Cited by-同舟云学术

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

Published:2016-11 Issue:11 Volume:27 Page:2090-2096
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ikeda M.,Shimizu S.,Sato T.,Morimoto M.,Kojima Y.,Inaba Y.,Hagihara A.,Kudo M.,Nakamori S.,Kaneko S.,Sugimoto R.,Tahara T.,Ohmura T.,Yasui K.,Sato K.,Ishii H.,Furuse J.,Okusaka T.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/11/2090/19446609/mdw323.pdf

Reference15 articles.

1. The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?;Abou-Alfa;Lancet Oncol,2013

2. Current status of hepatocellular carcinoma in Japan;Ikeda;Chin Clin Oncol,2013

3. Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy;Kudo;Liver Cancer,2012

4. Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma;Yoshikawa;Hepatol Res,2008

5. The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines;Heim;Anticancer Drugs,2005

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A deep learning model for personalized intra-arterial therapy planning in unresectable hepatocellular carcinoma: a multicenter retrospective study;eClinicalMedicine;2024-09

2. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis;World Journal of Gastrointestinal Oncology;2024-08-15

3. Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab;Journal of Hepatocellular Carcinoma;2024-07

4. Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts;Cancers;2024-06-28

5. Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review;Expert Review of Anticancer Therapy;2024-04-24